Allogeneic NK Cell (SMT bio)

N/A

Report date: 2023/03/15 10:34:33

Base Information

Drug NameAllogeneic NK Cell (SMT bio)

Drug Alias NameSMT-NKSMT-NK InjNatural killer cell therapy (SMT bio)SMT-01

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionNatural killer cell replacementsImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBiliary Tract Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesSmt Bio Co

China Registration ClassN/A

Develop Information

Active CompaniesSmt Bio Co Ltd

Inactive CompaniesN/A

Active IndicationsBiliary Tract Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A